Clinical Trial Update: Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is exploring polygenic risk-based detection of subclinical coronary atherosclerosis and intervention with statin and colchicine; recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• COLCHICINE (Colchicine)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING